Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
2 drugs for “c-MET”
Approved 1
- Telisotuzumab vedotinAbbVie Inc.c-MET
Phase 3 1
- Telisotuzumab adizutecanAbbVie Inc.c-MET
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.